ContraFect: Clinical Trials

1 trial sponsored by ContraFect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow ContraFect: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
CF-301, Placebo - Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
Phase 1CompletedContraFect202015-05-012020-04-07

Conditions studied

Bacteremia (1)

Interventions

exebacase (1)

Countries

United States (1)